Valazyd 40, 80 & 160 40 mg, 80 mg, 160 mg Tablet
PDF Leaflet Revision Date: 11 July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension, heart failure, and post-myocardial infarction.
Dosage (summary)
80 mg or 160 mg once daily for hypertension; 40 mg twice daily for heart failure.
Onset of Action / Duration
Onset: 2 weeks, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; can cause fetal harm.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
Contraindications
- Hypersensitivity to valsartan
- Severe renal impairment
- Pregnancy
- History of angioedema
Common side effects
- Hypotension
- Dizziness
- Hyperkalaemia
Counselling Points
- Monitor blood pressure regularly
- Avoid potassium supplements
- Report any signs of angioedema
Serious warnings
- Risk of hypotension in volume-depleted patients
- Angioedema risk
Important Disclaimer
The Valazyd 40, 80 & 160 40 mg, 80 mg, 160 mg Tablet professional information leaflet below is the property of Zydus Healthcare Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
